CAQ - Cambridge Acquisitio... Stock Analysis | Stock Taper
Logo
Cambridge Acquisition Corp. Class A Ordinary Shares

CAQ

Cambridge Acquisition Corp. Class A Ordinary Shares NASDAQ
$9.90 0.20% (+0.02)

Market Cap $247.34 M
52w High $10.10
52w Low $9.80
P/E 0
Volume 13.62K
Outstanding Shares 24.98M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $0 $250.91K $510.26K 0% $0.03 $-250.91K

What's going well?

The company earned $761,174 in interest income, which more than covered its operating costs and led to a small profit. No debt or tax burden this quarter.

What's concerning?

The company had zero revenue and lost money from its core operations. All profit came from interest, not from selling products or services, which is not sustainable long-term.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $949.4K $231.91M $8.21M $223.7M

What's financially strong about this company?

The company has no debt, lots of liquid assets, and a very high current ratio. Most of its value is in investments, making it very safe from a financial standpoint.

What are the financial risks or weaknesses?

Retained earnings are negative, so the company has lost money over time. There is no physical infrastructure or operating assets, and almost all value is in investments.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $510.26K $-274.42K $-230M $231.22M $949.4K $-274.42K

What's strong about this company's cash flow?

The company was able to raise a large amount of money by issuing new shares, boosting its cash position. There is no debt dependency, as some debt was paid down.

What are the cash flow concerns?

The business is burning cash from operations and only survives by selling huge amounts of new stock, which heavily dilutes existing shareholders. Cash flow from the core business is negative and not improving.

5-Year Trend Analysis

A comprehensive look at Cambridge Acquisition Corp. Class A Ordinary Shares's financial evolution and strategic trajectory over the past five years.

+ Strengths

CAQ has a clear thematic focus on high-growth, emerging health and wellness technologies, which positions it to benefit if it can secure the right partner. Its current cost base is lean, with limited overhead and no legacy operational baggage. The absence of past acquisitions or complex assets also means there are no inherited integration issues or immediate impairment risks. Structurally, it retains the flexibility to design a transaction that could align with fast-growing niches and investor interest in these themes.

! Risks

The financial profile shows severe weaknesses: no revenue, no cash, negative equity, and a heavy reliance on short-term obligations. Liquidity risk and going-concern risk are significant. Strategically, CAQ must compete with many better-capitalized buyers for a limited pool of attractive targets, under time pressure and within highly regulated industries that can shift quickly. Until a merger is identified and funded, there is material uncertainty around the company’s ability to stabilize its balance sheet and transition into a viable operating business.

Outlook

The outlook is highly uncertain and heavily dependent on execution. If CAQ can raise or access sufficient capital, secure a strong target in its chosen sectors, and navigate regulatory and market headwinds, the combined entity could benefit from exposure to growing health and wellness trends. Conversely, failure to close a compelling deal, difficulties in funding obligations, or adverse regulatory developments in areas like hemp and psychedelics could leave the company constrained or force it into an unfavorable resolution. Current financial statements primarily highlight risk and the need for successful transaction execution rather than any existing operational strength.